000 | 01419 a2200445 4500 | ||
---|---|---|---|
005 | 20250514011524.0 | ||
264 | 0 | _c20011101 | |
008 | 200111s 0 0 eng d | ||
022 | _a1354-523X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHiga, K | |
245 | 0 | 0 |
_aThe roles of the N-terminal portions of various tachykinins in promoting salivation. _h[electronic resource] |
260 |
_bOral diseases _cJul 2001 |
||
300 |
_a238-45 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aEledoisin _xpharmacology |
650 | 0 | 4 | _aInjections, Intraperitoneal |
650 | 0 | 4 |
_aIsoleucine _xpharmacology |
650 | 0 | 4 |
_aKassinin _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aModels, Animal |
650 | 0 | 4 |
_aNeurokinin A _xpharmacology |
650 | 0 | 4 |
_aNeurokinin B _xpharmacology |
650 | 0 | 4 |
_aPhenylalanine _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aSalivation _xdrug effects |
650 | 0 | 4 |
_aSerine _xpharmacology |
650 | 0 | 4 | _aStatistics as Topic |
650 | 0 | 4 |
_aSubmandibular Gland _xdrug effects |
650 | 0 | 4 |
_aTachykinins _xadministration & dosage |
650 | 0 | 4 |
_aTyrosine _xpharmacology |
650 | 0 | 4 |
_aValine _xpharmacology |
700 | 1 | _aGao, C | |
700 | 1 | _aMotokawa, W | |
700 | 1 | _aAbe, K | |
773 | 0 |
_tOral diseases _gvol. 7 _gno. 4 _gp. 238-45 |
|
999 |
_c11497555 _d11497555 |